Following a federal court ruling that blocked the mailing of the abortion pill mifepristone, its manufacturer and abortion providers have filed an emergency appeal to the US Supreme Court. The legal challenge seeks to restore nationwide access to the drug by mail, with warnings of potential chaos if the lower court's decision stands.